Discovery of novel septacidin congeners from a high yield heterologous expression strain Streptomyces albus 1597

J Antibiot (Tokyo). 2022 Mar;75(3):172-175. doi: 10.1038/s41429-022-00499-6. Epub 2022 Jan 26.

Abstract

Septacidin is an adenine nucleoside antibiotic with antifungal and antitumor activities. During the efforts to construct a better septacidin producer, we obtained a high yield strain S. albus 1597 by putting the biosynthetic gene cluster (BGC) of septacidin under the control of the constitutive strong promoter ermE*. S. albus 1597 could produce new septacidin congeners SEP-538 and SEP-552 with shorter fatty acyl chains. Moreover, SEP-624 with an unprecedented hydroxylated fatty acyl chain was also isolated from this titre improved strain, enriching the diversity of septacidins. SEP-552 showed moderate inhibitory effects against Epidermophyton floccosum 57312 with MIC value 62.5 μM, while SEP-538 and SEP-624 only exhibited weak antifungal activities. The structure-activity relationship investigation revealed that the antifungal activity of septacidins is significantly influenced by the length of and the decoration on their fatty acyl chains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / biosynthesis
  • Epidermophyton / genetics
  • Multigene Family / genetics
  • Purine Nucleosides / genetics
  • Streptomyces / genetics*
  • Streptomyces griseus / genetics

Substances

  • Anti-Bacterial Agents
  • Purine Nucleosides
  • septacidin

Supplementary concepts

  • Epidermophyton floccosum
  • Streptomyces albus